McLean, VA, United States of America

Abner L Notkins

This inventor holds 3 USPTO granted patents. Top assignees: The United States of America as Represented by the Department of Health, The United States of America, as Represented by the Secretary, Department of Health and Human Services, University of Florida Research Foundation Inc.. Active years: 1999-2002.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Abner L Notkins. Retrieved from https://idiyas.com/inventor/abner-l-notkins

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 2.8

ph-index = 3

Forward Citations = 16(Granted Patents)


Company Filing History:


Years Active: 1999-2002

Loading Chart...
3 patents (USPTO):Explore Patents

Title: Abner L Notkins: Innovator in Diabetes Detection and Cancer Diagnosis

Introduction

Abner L Notkins is a notable inventor based in McLean, VA (US), recognized for his contributions to medical diagnostics. He holds a total of 3 patents that focus on innovative methods for detecting diabetes and cancer. His work has significantly impacted the fields of endocrinology and oncology.

Latest Patents

One of Notkins' latest patents is titled "Materials and methods for detection of insulin dependent diabetes." This invention provides an effective and reliable substitute for the currently employed ICA assay for diabetes. By offering a method for detecting autoantibodies to both GAD and IA-2 auto-antigens, it enhances the reliability of chemical assays. Additionally, these antigens may be utilized in therapeutic regimens aimed at achieving immune tolerance, thereby improving clinical outcomes. Another significant patent is "Human insulinoma-associated cDNA," which discloses a novel insulinoma-associated, neuroendocrine tumor-associated cDNA sequence. This sequence and its fragments are useful for diagnosing and identifying insulinoma and neuroendocrine tumors. The invention relates to a method for identifying cancer using the insulinoma-associated nucleic acid, polypeptide, and the antibodies generated from it.

Career Highlights

Throughout his career, Notkins has worked with esteemed organizations, including the United States of America as represented by the Department of Health and the United States of America, as represented by the Secretary, Department of Health and Human Services. His work in these institutions has contributed to advancements in public health and medical research.

Collaborations

Notkins has collaborated with notable colleagues such as Michael S Lan and Noel K Maclaren. These partnerships have fostered innovation and have been instrumental in the development of his patented technologies.

Conclusion

Abner L Notkins is a distinguished inventor whose work in diabetes detection and cancer diagnosis has made a significant impact on medical science. His innovative patents continue to pave the way for advancements in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…